Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2025-04-04

Clinical Trial Update: Effect of L-carnitine Supplementation on Phenylalanine and Brain-derived Neurotrophic Factor Levels in Infants and Children With Phenylketonuria [Phase 4]

View source ↗

Summary

This Phase 4 clinical trial update describes evaluating L-carnitine supplementation for its effect on phenylalanine and brain-derived neurotrophic factor levels…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • L-carnitine (L-carnitine)

Snippet

Sponsor: Mansoura University | Conditions: Phenylketonuria | Phase 4 | Status: ACTIVE_NOT_RECRUITING